RBC
CELG

Roble Belko & Company’s Celgene Corp CELG Stock Holding History

Roble Belko & Company’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-144
Closed -$14K – 370
2019
Q1 		$14K Hold
144
– – ﹤0.01% 198
2018
Q4 		$9K Sell
144
-67
-32% -$4.95K ﹤0.01% 217
2018
Q3 		$19K Hold
211
– – 0.01% 168
2018
Q2 		$17K Hold
211
– – 0.01% 181
2018
Q1 		$19K Hold
211
– – 0.01% 182
2017
Q4 		$22K Buy
211
+144
+215% +$16.2K 0.01% 165
2017
Q3 		$10K Hold
67
– – ﹤0.01% 194
2017
Q2 		$9K Hold
67
– – ﹤0.01% 205
2017
Q1 		$8K Hold
67
– – ﹤0.01% 229
2016
Q4 		$8K Sell
67
-407
-86% -$45.3K ﹤0.01% 242
2016
Q3 		$50K Buy
+474
New +$51.3K 0.03% 112

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Roble Belko & Company's CELG Position: Q2 2019 in Review

Roble Belko & Company sold out of Celgene Corp (CELG) in Q2 2019, closing a stake of 144 shares — an estimated $14K sold.

Roble Belko & Company first reported a position in CELG in Q3 2016 and held it in 11 quarters. The position peaked at $50K in Q3 2016. 1,287 funds tracked by Wall St. Rank hold CELG as of Q2 2019.

  • Roble Belko & Company reported no remaining Celgene Corp position as of Q2 2019 after selling out during the quarter.
  • Roble Belko & Company sold 144 Celgene Corp shares in Q2 2019, an estimated $14K.
  • Roble Belko & Company first reported a position in Celgene Corp in Q3 2016 and held it in 11 quarters.
  • Roble Belko & Company's Celgene Corp position peaked at $50K in Q3 2016.
  • 1,287 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2019.

Based on Roble Belko & Company's 13F filing for Q2 2019, filed 13 Aug 2019.